Anthony G. Coyne

3.4k citations

62 papers · 2.7k indexed · 1 hit paper · h-index 22

Co-authors: Richard N. Butler Chris Abell Duncan E. Scott Sean A. Hudson Luke A. Burke Tom L. Blundell Daniel Shiu‐Hin Chan Martin D. Smith
Topics: Tuberculosis Research and Epidemiology (21 papers)Biochemical and Molecular Research (17 papers)Enzyme Structure and Function (12 papers)
Cited by: Organic Chemistry Inorganic Chemistry Molecular Biology
Journals: Chemical Reviews Proceedings of the National Academy of Sciences Journal of the American Chemical Society
Partner nations: United Kingdom United States Ireland

In The Last Decade

Anthony G. Coyne

60 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Water: Nature’s Reaction Enforcer—Comparative Effects for Organic Synthesis “In-Water” and “On-Water”

2010 994 citations Anthony G. Coyne et al. profile →

Peers

Countries citing papers authored by Anthony G. Coyne

Since Specialization

Citations

This map shows the geographic impact of Anthony G. Coyne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony G. Coyne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony G. Coyne more than expected).

Fields of papers citing papers by Anthony G. Coyne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony G. Coyne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony G. Coyne. The network helps show where Anthony G. Coyne may publish in the future.

Co-authorship network of co-authors of Anthony G. Coyne

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony G. Coyne. A scholar is included among the top collaborators of Anthony G. Coyne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony G. Coyne. Anthony G. Coyne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fragment-Based Development of Small Molecule Inhibitors Targeting Mycobacterium tuberculosis Cholesterol Metabolism 2025 ·Journal of Medicinal Chemistry ·Madeline E. Kavanagh,Kirsty J. McLean,(unknown),(unknown),M. Snee,Richard B. Tunnicliffe,Kriti Arora,Helena I. Boshoff,Alexander Fanourakis,María José Rebollo-López,Fátima Ortega,Colin Levy,Andrew W. Munro,David Leys,Chris Abell,Anthony G. Coyne	0
2	A Fragment‐Based Competitive ¹⁹F LB‐NMR Platform For Hotspot‐Directed Ligand Profiling 2024 ·Angewandte Chemie International Edition ·William J. McCarthy,S.E. Thomas,(unknown),(unknown),R. Andres Floto,Glyn Williams,Tom L. Blundell,Anthony G. Coyne,Chris Abell	0
3	A Fragment‐Based Competitive ¹⁹F LB‐NMR Platform For Hotspot‐Directed Ligand Profiling 2024 ·Angewandte Chemie ·William J. McCarthy,S.E. Thomas,(unknown),(unknown),R. Andres Floto,Glyn Williams,Tom L. Blundell,Anthony G. Coyne,Chris Abell	1
4	Chemical Validation of Mycobacterium tuberculosis Phosphopantetheine Adenylyltransferase Using Fragment Linking and CRISPR Interference** 2023 ·Angewandte Chemie International Edition ·Jamal El Bakali,M. Błaszczyk,Joanna C. Evans,(unknown),William J. McCarthy,(unknown),M.V.B. Dias,Eachan O. Johnson,Anthony G. Coyne,Valerie Mizrahi,Tom L. Blundell,Chris Abell,Christina Spry	8
5	Chemical Validation of Mycobacterium tuberculosis Phosphopantetheine Adenylyltransferase Using Fragment Linking and CRISPR Interference** 2023 ·Angewandte Chemie ·Jamal El Bakali,M. Błaszczyk,Joanna C. Evans,(unknown),William J. McCarthy,(unknown),M.V.B. Dias,Eachan O. Johnson,Anthony G. Coyne,Valerie Mizrahi,Tom L. Blundell,Chris Abell,Christina Spry	1
6	Fragment‐Merging Strategies with Known Pyrimidine Scaffolds Targeting Dihydrofolate Reductase from Mycobacterium tuberculosis 2023 ·ChemMedChem ·(unknown),(unknown),(unknown),(unknown),Chris Abell,Manuela Tosin,Anthony G. Coyne,M.V.B. Dias	1
7	Development of Inhibitors of SAICAR Synthetase (PurC) from Mycobacterium abscessus Using a Fragment-Based Approach 2022 ·ACS Infectious Diseases ·Sitthivut Charoensutthivarakul,S.E. Thomas,(unknown),Karen Brown,Juan M. Belardinelli,Andrew Whitehouse,(unknown),(unknown),(unknown),Mary Jackson,V. Mendes,R. Andres Floto,Tom L. Blundell,Anthony G. Coyne,Chris Abell	10
8	A new strategy for hit generation: Novel in cellulo active inhibitors of CYP121A1 from Mycobacterium tuberculosis via a combined X-ray crystallographic and phenotypic screening approach (XP screen) 2022 ·European Journal of Medicinal Chemistry ·Martyn Frederickson,(unknown),Dimitrios Evangelopoulos,Kirsty J. McLean,(unknown),Richard B. Tunnicliffe,(unknown),Madeline E. Kavanagh,Sitthivut Charoensutthivarakul,Richard T. Blankley,Colin Levy,Luiz Pedro S. de Carvalho,David Leys,Andrew W. Munro,Anthony G. Coyne,Chris Abell	5
9	Microfluidic preparation of composite hydrogel microparticles for the staining of microalgal cells 2022 ·Colloids and Surfaces B Biointerfaces ·(unknown),Ziyi Yu,Jeannine Hess,Katrin Geisler,Alison G. Smith,Anthony G. Coyne,Chris Abell	3
10	Targeting Mycobacterium tuberculosis CoaBC through Chemical Inhibition of 4′-Phosphopantothenoyl-l-cysteine Synthetase (CoaB) Activity 2021 ·ACS Infectious Diseases ·Joanna C. Evans,(unknown),John Post,V. Mendes,Zhe Wang,Navid Nahiyaan,(unknown),Stephen Thompson,Simon R. Green,Peter C. Ray,Jeannine Hess,Christina Spry,Anthony G. Coyne,Chris Abell,Helena I. Boshoff,Paul G. Wyatt,Kyu Y. Rhee,Tom L. Blundell,Clifton E. Barry,Valerie Mizrahi	6
11	Fragment-based discovery of a new class of inhibitors targeting mycobacterial tRNA modification 2020 ·Nucleic Acids Research ·S.E. Thomas,Andrew Whitehouse,Karen Brown,Sophie Burbaud,Juan M. Belardinelli,(unknown),Ramanuj Lahiri,M. Daben J. Libardo,Pooja Gupta,Sony Malhotra,Helena I. Boshoff,Mary Jackson,Chris Abell,Anthony G. Coyne,Tom L. Blundell,R. Andres Floto,V. Mendes	18
12	Development of Inhibitors against Mycobacterium abscessus tRNA (m ¹ G37) Methyltransferase (TrmD) Using Fragment-Based Approaches 2019 ·Journal of Medicinal Chemistry ·Andrew Whitehouse,S.E. Thomas,Karen Brown,Alexander Fanourakis,Daniel Shiu‐Hin Chan,M. Daben J. Libardo,V. Mendes,Helena I. Boshoff,R. Andres Floto,Chris Abell,Tom L. Blundell,Anthony G. Coyne	33
13	Targeting of Fumarate Hydratase from Mycobacterium tuberculosis Using Allosteric Inhibitors with a Dimeric-Binding Mode 2019 ·Journal of Medicinal Chemistry ·Andrew Whitehouse,M. Daben J. Libardo,Monica Kasbekar,P. Brear,Gerhard W. Fischer,Craig J. Thomas,Clifton E. Barry,Helena I. Boshoff,Anthony G. Coyne,Chris Abell	7
14	Covalent inactivation of Mycobacterium thermoresistibile inosine-5′-monophosphate dehydrogenase (IMPDH) 2019 ·Bioorganic & Medicinal Chemistry Letters ·Ana Trapero,A. Pacitto,Daniel Shiu‐Hin Chan,Chris Abell,Tom L. Blundell,David B. Ascher,Anthony G. Coyne	1
15	Allosteric Small-Molecule Serine/Threonine Kinase Inhibitors 2019 ·Advances in experimental medicine and biology ·Resmi C. Panicker,Souvik Chattopadhaya,Anthony G. Coyne,Rajavel Srinivasan	14
16	Effect of DMSO on Protein Structure and Interactions Assessed by Collision-Induced Dissociation and Unfolding 2017 ·Analytical Chemistry ·(unknown),Madeline E. Kavanagh,Kirsty J. McLean,Andrew W. Munro,Dijana Matak‐Vinković,Anthony G. Coyne,Chris Abell	48
17	Small‐Molecule Inhibitors That Target Protein–Protein Interactions in the RAD51 Family of Recombinases 2014 ·ChemMedChem ·Duncan E. Scott,Anthony G. Coyne,Ashok R. Venkitaraman,Tom L. Blundell,Chris Abell,Marko Hyvönen	30
18	Overcoming the Limitations of Fragment Merging: Rescuing a Strained Merged Fragment Series Targeting Mycobacterium tuberculosis CYP121 2013 ·ChemMedChem ·Sean A. Hudson,Sachin Surade,Anthony G. Coyne,Kirsty J. McLean,David Leys,Andrew W. Munro,Chris Abell	27
19	Asymmetric electrocyclic reactions 2011 ·Chemical Society Reviews ·Sam Thompson,Anthony G. Coyne,Peter C. Knipe,Martin D. Smith	70
20	Drugging challenging targets using fragment-based approaches 2010 ·Current Opinion in Chemical Biology ·Anthony G. Coyne,Duncan E. Scott,Chris Abell	64

About Anthony G. Coyne

Anthony G. Coyne is a scholar working on Infectious Diseases, Pharmacology and Organic Chemistry, having authored 62 papers that have together received 2.7k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (21 papers), Biochemical and Molecular Research (17 papers) and Enzyme Structure and Function (12 papers). The work is most often cited by research in Organic Chemistry (1.7k citations), Inorganic Chemistry (270 citations) and Molecular Biology (1.1k citations). Anthony G. Coyne has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include Richard N. Butler, Chris Abell, Duncan E. Scott, Sean A. Hudson, Luke A. Burke, Tom L. Blundell, Daniel Shiu‐Hin Chan, Martin D. Smith, Patrick J. Guiry and Kirsty J. McLean. Their work appears in journals such as Chemical Reviews, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact